Jiong Li’s research focuses on understanding the oncogenic signaling pathways and developing novel strategies for the eradication of cancer. He has made significant contributions in the regulation of Wnt/beta-catenin pathway, a fundamental signaling that determines cell fate and promotes tumorigenesis. His work has been published in the high-impacted journals including Nature Cell Biology, Cell Stem Cell, Nature Communications, Molecular Therapy, Cell Reports, and Oncogene.

Current research in Li’s lab includes:

1. Targeting epigenetic control of cancer stem cells;
2. Molecular regulation of head and neck cancer development and metastasis;
3. Novel PROTAC molecules for the treatment of human cancer; and
4. Immunotherapy of head and neck cancer.

• Ph.D., Chinese Academy of Sciences

Postgraduate Training

• University of Michigan, UCLA